Sana Biotechnology
Nasdaq SANA · Seattle, WA
Works in Cardiovascular · Dermatology · Hematology · Immunology · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Sana Biotechnology is a clinical trial sponsor based in Seattle, WA, listed as Nasdaq SANA. It has 3 active clinical trials with 29 planned participants, across 9 therapeutic areas.
Trial track record · since 2021
Financials · Nasdaq SANA
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Sana Biotechnology
Sana Biotechnology is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 29 planned participants, in Cardiovascular, Dermatology, Hematology, Immunology and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
Sana Biotechnology is based in Seattle, WA and is listed as Nasdaq SANA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Sana Biotechnology; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-11-28.
Approve Suite is not affiliated with Sana Biotechnology.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.